Alzamend Neuro Stock Quote ALZN - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.56

Bid

0.532

Ask

0.56

Volume

250,590

0.00 Day's Range 0.00

0.4388 52 Week Range 11.91

Market Cap

3.774M

Previous Close

0.528

Open

Last Trade

0.532

Last Trade Time

08:35:28

Financial Volume

VWAP

Average Volume (3m)

68,110

Shares Outstanding

7,120,703

Dividend Yield

PE Ratio

-0.25

Earnings Per Share (EPS)

-2.09

Revenue

Net Profit

-14.88M

Alzamend Neuro Inc is an early clinical stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipe... Alzamend Neuro Inc is an early clinical stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.alzamend.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Alzamend Neuro Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ALZN. The last closing price for Alzamend Neuro was $0.53. Over the last year, Alzamend Neuro shares have traded in a share price range of $ 0.4388 to $ 11.91.

Alzamend Neuro currently has 7,120,703 shares outstanding. The market capitalization of Alzamend Neuro is $3.77 million. Alzamend Neuro has a price to earnings ratio (PE ratio) of -0.25.

Alzamend Neuro Announces Agreement for Registered Direct Offering and Concurrent Private Placement for an Aggregate of up to $25 Million

Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease (“Alzheimer’s”), bipolar...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.18	-24.3243243243	0.74	0.74	0.4388	127250	0.57668855	CS
4	-0.3675	-39.6226415094	0.9275	0.9275	0.4388	58419	0.64707517	CS
12	-0.34	-37.7777777778	0.9	1.29	0.4388	68110	0.92635021	CS
26	-1.04	-65	1.6	1.92	0.4388	102334	1.12778215	CS
52	-7.24	-92.8205128205	7.8	11.91	0.4388	148697	4.05503453	CS
156	-434.44	-99.8712643678	435	503.25	0.4388	1203922	41.95018824	CS
260	-434.44	-99.8712643678	435	503.25	0.4388	1203922	41.95018824	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CPOPPop Culture Group Company Ltd	$ 3.18 (87.06%)	9.38M
SEZLSezzle Inc	$ 65.49 (46.38%)	32.46k
IVPInspire Veterinary Partners Inc	$ 5.03 (38.57%)	5.19M
GWAVGreenwave Technology Solutions Inc	$ 0.0728 (25.30%)	40.51M
ZLABZai Lab Ltd	$ 20.05 (21.00%)	87.45k
EMKREMCORE Corporation	$ 1.70 (-41.38%)	135.47k
TIVCTivic Health Systems Inc	$ 0.8599 (-35.83%)	676.05k
CTMXCytomX Therapeutics Inc	$ 2.93 (-30.07%)	4.99M
FWRDForward Air Corporation	$ 15.22 (-29.24%)	73.67k
CDLXCardlytics Inc	$ 10.40 (-28.77%)	77.99k
GWAVGreenwave Technology Solutions Inc	$ 0.0728 (25.30%)	40.51M
CPOPPop Culture Group Company Ltd	$ 3.18 (87.06%)	9.38M
IVPInspire Veterinary Partners Inc	$ 5.03 (38.57%)	5.19M
CTMXCytomX Therapeutics Inc	$ 2.93 (-30.07%)	4.99M
PEGYPineapple Energy Inc	$ 0.0656 (-6.29%)	4.52M